Zacks Research Brokers Lift Earnings Estimates for Core Laboratories Inc. (NYSE:CLB)

Core Laboratories Inc. (NYSE:CLB) – Equities researchers at Zacks Research upped their Q4 2025 earnings estimates for Core Laboratories in a research report issued on Thursday, September 5th. Zacks Research analyst T. Saha now expects that the oil and gas company will post earnings per share of $0.31 for the quarter, up from their prior estimate of $0.28. The consensus estimate for Core Laboratories’ current full-year earnings is $0.79 per share. Zacks Research also issued estimates for Core Laboratories’ Q2 2026 earnings at $0.23 EPS.

Other equities research analysts also recently issued research reports about the stock. Bank of America reduced their price target on shares of Core Laboratories from $16.00 to $15.00 and set an “underperform” rating for the company in a research report on Monday, July 15th. StockNews.com upgraded Core Laboratories from a “sell” rating to a “hold” rating in a research note on Friday, July 26th. Stifel Nicolaus upped their price target on Core Laboratories from $18.00 to $22.00 and gave the company a “hold” rating in a report on Friday, July 26th. Finally, Piper Sandler reduced their price objective on Core Laboratories from $18.00 to $17.00 and set a “neutral” rating for the company in a report on Monday, July 15th. Two investment analysts have rated the stock with a sell rating and three have assigned a hold rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus target price of $18.50.

Core Laboratories Stock Down 2.3 %

NYSE:CLB opened at $17.29 on Monday. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.68 and a current ratio of 2.39. The firm has a market cap of $811.07 million, a P/E ratio of 19.65, a P/E/G ratio of 1.01 and a beta of 2.37. Core Laboratories has a fifty-two week low of $13.82 and a fifty-two week high of $26.47. The firm has a 50-day simple moving average of $20.71 and a two-hundred day simple moving average of $18.46.

Core Laboratories (NYSE:CLB) last released its earnings results on Wednesday, July 24th. The oil and gas company reported $0.22 EPS for the quarter, topping analysts’ consensus estimates of $0.21 by $0.01. The firm had revenue of $130.58 million for the quarter, compared to analysts’ expectations of $132.85 million. Core Laboratories had a return on equity of 15.20% and a net margin of 5.44%. The company’s quarterly revenue was up 2.1% on a year-over-year basis. During the same period in the prior year, the firm posted $0.23 earnings per share.

Institutional Trading of Core Laboratories

Hedge funds have recently bought and sold shares of the company. Headlands Technologies LLC purchased a new position in Core Laboratories in the second quarter worth about $36,000. Quadrant Capital Group LLC boosted its holdings in shares of Core Laboratories by 84.0% in the fourth quarter. Quadrant Capital Group LLC now owns 3,370 shares of the oil and gas company’s stock worth $60,000 after buying an additional 1,538 shares during the last quarter. GAMMA Investing LLC grew its position in Core Laboratories by 31.6% during the first quarter. GAMMA Investing LLC now owns 3,570 shares of the oil and gas company’s stock valued at $61,000 after buying an additional 857 shares during the period. CWM LLC grew its position in Core Laboratories by 1,178.6% during the first quarter. CWM LLC now owns 3,580 shares of the oil and gas company’s stock valued at $61,000 after buying an additional 3,300 shares during the period. Finally, Lindbrook Capital LLC increased its holdings in Core Laboratories by 19.7% during the first quarter. Lindbrook Capital LLC now owns 3,713 shares of the oil and gas company’s stock valued at $63,000 after buying an additional 612 shares during the last quarter. Hedge funds and other institutional investors own 97.81% of the company’s stock.

Core Laboratories Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Monday, August 26th. Stockholders of record on Monday, August 5th were paid a $0.01 dividend. The ex-dividend date was Monday, August 5th. This represents a $0.04 dividend on an annualized basis and a dividend yield of 0.23%. Core Laboratories’s dividend payout ratio (DPR) is currently 4.55%.

Core Laboratories Company Profile

Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.